Stock Market Declining
The market has lost further grounds on account of huge selling pressure continued in the selective scrips. The broader market is trading flat today as the Mid Cap is trading marginally lower while the Small Cap managed to trade in green. The Capital Goods, Oil & Gas, Bank and IT stocks are out of favor today while the sustained buying is seen in the Metal, FMCG and Realty stocks. The overall market breadth turns negative, as 1219 stocks are advancing while 1299 stocks are declining and the 57 stocks remained unchanged on BSE.
The BSE Mid cap is lower by 40 points at 6,231 while the BSE small Cap advanced by 12 points to trade at 7,451.
At 12.30 pm, BSE Sensex was at 15,899 down by 188 points and Nifty was at 4,789.90 down by 38.95 points.
BSE Metal index inclined by 17.05 points to trade at 13,762.23. The major gainers are Gujarat NRE (6.35%), Hindalco Industries (5.07%), NALCO (4.02%) and Bhusan Steel (1.10%).
BSE Capital goods index dropped by 172.84 points to 13,621.20. The main losers are Siemens (2.75%), BEML (2.48%), Bharat Electrical (1.91%) and Havells India (2.70%).
BSE Banks index slipped by 147.69 points to trade at 8,154.11. The top losers are AXIX Bank (3.70%), Bank of India (2.92%), Yes Bank (1.65%) and HDFC Bank (1.54%).
BSE Health Care index inclined marginally by 0.75 points to trade at 3,738.26 as Sun Pharma (2.52%), Cipla (1.58%), Lupin (1.29%), Glaxosmith (1.90%) and Pfizer (0.43%) are trading in positive.
Sun pharmaceuticals has received the USFDA approval for the abbreviated new drug application to market a generic version of forest Lab’s Tessalon, benzonatate capsules.
Cipla has developed a combination of drugs including the medicines for allergic rhinitis, asthama and cardiac-problems for the developed markets. The company expects to bring the allergic rhinitis drug into the market next year and the other two combination drugs in the asthama and cardiac are expected by 2010.
[Via]
Posted on 27th March 2008
Under: Apple stock, Stock, Stock Market, Stock market news | No Comments »